Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 8 of 16 for:    meybohm
Previous Study | Return to List | Next Study

Preoperative Anaemia prevaLence In surgiCal patiEnts (ALICE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03978260
Recruitment Status : Recruiting
First Posted : June 7, 2019
Last Update Posted : March 29, 2022
Sponsor:
Collaborators:
Medical University of Vienna
University Hospital, Angers
Medical University of Graz
Hospital Universitari del Mar de Barcelona
Royal Marsden NHS Foundation Trust
Hospital Hietzing
University of Zurich
University Hospital Frankfurt
Auckland City Hospital
Information provided by (Responsible Party):
Dr. Patrick Meybohm, M.D., Johann Wolfgang Goethe University Hospital

Study Description
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:

Preoperative anaemia is common in surgery, with a prevalence between 10 and 50 %, and is an independent risk factor for morbidity and mortality.

Anaemia is mostly the result of an inadequate erythropoiesis due to iron deficiency, lack of vitamin B12 or folate, and bone marrow diseases. Among the elderly, renal disease and chronic inflammation account for approximately one-third of all anaemia incidences. The aim of this study is to provide detailed data about the prevalence of preoperative deficiencies in iron, vitamin B12 and/or folate and the presence of underlying renal or chronic diseases in patients undergoing major surgery.


Condition or disease
Anemia Iron-deficiency Folic Acid Deficiency Vitamin B 12 Deficiency Anaemia of Renal Disease Anemia of Chronic Inflammation

Detailed Description:
Preoperative anaemia is common in surgery, with a prevalence between 10 and 50 %, and is an independent risk factor for morbidity and mortality. Due to the potential risk of additional blood loss, anaemia represents a serious disease condition within the surgical field. Especially patients undergoing major elective surgery are at risk of substantial blood loss. Anaemia is mostly the result of an inadequate erythropoiesis due to iron deficiency, lack of vitamin B12 or folate, and bone marrow diseases. Among the elderly, renal disease and chronic inflammation account for approximately one-third of all anaemia incidences. The aim of this study is to provide detailed data about the prevalence of preoperative deficiencies in iron, vitamin B12 and/or folate and the presence of underlying renal or chronic diseases in patients undergoing major surgery. Results will facilitate design of supplementation strategies to improve haemoglobin level before surgery.
Study Design
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Observational
Estimated Enrollment : 1500 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Preoperative Anaemia Prevalence in Surgical Patients- A Prospective, International, Multicentre Observational Study (ALICE)
Actual Study Start Date : August 30, 2019
Estimated Primary Completion Date : September 2022
Estimated Study Completion Date : December 31, 2022

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Anemia

Groups and Cohorts
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information


Outcome Measures
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Prevalence of preoperative anaemia [ Time Frame: prior surgery ]
    Hemoglobin level


Secondary Outcome Measures :
  1. Number of patients with red blood cell transfusion [ Time Frame: 30 day ]
    Amount of transfused units per patient

  2. Number of patient with revision [ Time Frame: 90 day ]
    Number of patients with Revision after surgery

  3. Number of patients with mortality [ Time Frame: 90 day ]
    in-hospital

  4. Re-admission [ Time Frame: up to 90 days after discharge ]
    Re-admission rates up to 90 days

  5. Hospital and ICU length of stay [ Time Frame: 30 days ]
    Time from Admission till discharge

  6. Incidence of hospital-acquired anaemia [ Time Frame: 30 days ]
    Hemoglobin level


Eligibility Criteria
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Major surgical patients
Criteria

Inclusion Criteria:

  • Age ≥ 18 years
  • Written informed consent prior to study participating according to the national law requirements
  • Patients undergoing major surgery
  • Expected hospital stay with a minimum of 24 hours

Exclusion Criteria:

  • Preoperative autologous blood donation
  • Patients with expected re-surgery within the planned 7-day recruitment period
Contacts and Locations
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03978260


Locations
Layout table for location information
Germany
Johann Wolfgang Goethe University Hospital Recruiting
Frankfurt am Main, Hesse, Germany, 60590
Contact: Patrick Meybohm, Prof. Dr.    +49 (0) 69 630187461    patrick.meybohm@kgu.de   
Contact: Suma Choorapoikayil, Dr.    +49 (0) 69 630183169    suma.choorapoikayil@kgu.de   
Sponsors and Collaborators
Johann Wolfgang Goethe University Hospital
Medical University of Vienna
University Hospital, Angers
Medical University of Graz
Hospital Universitari del Mar de Barcelona
Royal Marsden NHS Foundation Trust
Hospital Hietzing
University of Zurich
University Hospital Frankfurt
Auckland City Hospital
More Information
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Layout table for additonal information
Responsible Party: Dr. Patrick Meybohm, M.D., Principal Investigator, Johann Wolfgang Goethe University Hospital
ClinicalTrials.gov Identifier: NCT03978260    
Other Study ID Numbers: E35/19
First Posted: June 7, 2019    Key Record Dates
Last Update Posted: March 29, 2022
Last Verified: March 2022
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Dr. Patrick Meybohm, M.D., Johann Wolfgang Goethe University Hospital:
Anemia
Additional relevant MeSH terms:
Layout table for MeSH terms
Anemia
Vitamin B 12 Deficiency
Folic Acid Deficiency
Inflammation
Pathologic Processes
Hematologic Diseases
 Vitamin B Deficiency
Avitaminosis
Deficiency Diseases
Malnutrition
Nutrition Disorders